Ovid Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of March 2021: 0.00x

Ovid Therapeutics Inc cash flow reinvestment rate. Ovid Therapeutics Inc (OVID) has a Cash Flow Reinvestment Rate of 0.00x as of March 2021, reinvesting $23.03K (capex $11.51K plus investments $-11.51K) from operating cash flow of $160.90 Million. Explore how well can Ovid Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

$23.03K

Capex + Investments

Operating Cash Flow

$160.90 Million

USD

Capital Expenditures

$11.51K

USD

Cash Flow Reinvestment Rate of Ovid Therapeutics Inc (2021–2021)

Cash flow reinvestment rate of Ovid Therapeutics Inc from 2021 to 2021. Historical reinvestment intensity for Ovid Therapeutics Inc across 1 annual periods. Explore OVID capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Ovid Therapeutics Inc Cash Flow Reinvestment Rate by Year (2021–2021)

Ovid Therapeutics Inc cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for Ovid Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Ovid Therapeutics Inc.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2021	0.02x	$1.82 Million	$118.61 Million	$189.41K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow